CIMM (founded in Nov. 2010) is the predecessor to state-owned research institute (founded in 1984). The first research in China to undertake the national-level project “Sodium Hyaluronate”.
The first domestic company obtained the CFDA certification of the State Food and Drug Administration.
The company completed the restructuring in 2010 and built a new plant with a total investment of 500 million yuan in the Changzhou Life and Health Industrial Park.
State-level high-tech enterprises, state-level three types of medical device manufacturers.